157 related articles for article (PubMed ID: 27338943)
1. In vivo proinflammatory activity of generations 0-3 (G0-G3) polyamidoamine (PAMAM) nanoparticles.
Durocher I; Girard D
Inflamm Res; 2016 Sep; 65(9):745-55. PubMed ID: 27338943
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the in vitro and in vivo proinflammatory activities of gold (+) and gold (-) nanoparticles.
Durocher I; Noël C; Lavastre V; Girard D
Inflamm Res; 2017 Nov; 66(11):981-992. PubMed ID: 28676918
[TBL] [Abstract][Full Text] [Related]
3. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
Dong Z; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
[TBL] [Abstract][Full Text] [Related]
4. Titanium dioxide (TiO2) nanoparticles induce neutrophil influx and local production of several pro-inflammatory mediators in vivo.
Gonçalves DM; Girard D
Int Immunopharmacol; 2011 Aug; 11(8):1109-15. PubMed ID: 21426949
[TBL] [Abstract][Full Text] [Related]
5. Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats.
Dong Z; Hamid KA; Gao Y; Lin Y; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2011 May; 100(5):1866-78. PubMed ID: 21374620
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
7. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
8. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
9. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin.
Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B
Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144
[TBL] [Abstract][Full Text] [Related]
10. Transdermal delivery of 8-methoxypsoralene mediated by polyamidoamine dendrimer G2.5 and G3.5--in vitro and in vivo study.
Borowska K; Wołowiec S; Głowniak K; Sieniawska E; Radej S
Int J Pharm; 2012 Oct; 436(1-2):764-70. PubMed ID: 22884834
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Absorption-Enhancement and the Mechanism of the PAMAM Dendrimer on Poorly Absorbable Drugs.
Lu J; Li N; Gao Y; Li N; Guo Y; Liu H; Chen X; Zhu C; Dong Z; Yamamoto A
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103462
[TBL] [Abstract][Full Text] [Related]
12. Effects of Polyamidoamine Dendrimers on a 3-D Neurosphere System Using Human Neural Progenitor Cells.
Zeng Y; Kurokawa Y; Zeng Q; Win-Shwe TT; Nansai H; Zhang Z; Sone H
Toxicol Sci; 2016 Jul; 152(1):128-44. PubMed ID: 27125967
[TBL] [Abstract][Full Text] [Related]
13. [The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine].
Lu JJ; Wu ZH; Ping QN
Yao Xue Xue Bao; 2009 Feb; 44(2):197-202. PubMed ID: 19408693
[TBL] [Abstract][Full Text] [Related]
14. PAMAM G4 dendrimers affect the aggregation of α-synuclein.
Milowska K; Malachowska M; Gabryelak T
Int J Biol Macromol; 2011 Jun; 48(5):742-6. PubMed ID: 21382406
[TBL] [Abstract][Full Text] [Related]
15. Intratumor Performance and Therapeutic Efficacy of PAMAM Dendrimers Carried by Clustered Nanoparticles.
Li HJ; Liu J; Luo YL; Chen SB; Liu R; Du JZ; Wang J
Nano Lett; 2019 Dec; 19(12):8947-8955. PubMed ID: 31694380
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
17. Effects of PAMAM dendrimers with various surface functional groups and multiple generations on cytotoxicity and neuronal differentiation using human neural progenitor cells.
Zeng Y; Kurokawa Y; Win-Shwe TT; Zeng Q; Hirano S; Zhang Z; Sone H
J Toxicol Sci; 2016; 41(3):351-70. PubMed ID: 27193728
[TBL] [Abstract][Full Text] [Related]
18. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.
Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F
Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809
[TBL] [Abstract][Full Text] [Related]
19. Association of small aromatic molecules with PAMAM dendrimers.
DeFever RS; Sarupria S
Phys Chem Chem Phys; 2015 Nov; 17(44):29548-57. PubMed ID: 26395843
[TBL] [Abstract][Full Text] [Related]
20. Study of the interactions of PAMAM G3-NH2 and G3-OH dendrimers with 5-fluorouracil in aqueous solutions.
Buczkowski A; Waliszewski D; Urbaniak P; Palecz B
Int J Pharm; 2016 May; 505(1-2):1-13. PubMed ID: 27039147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
